EastGate Biotech Corp., a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes, entered into a long term strategic alliance with MJ Biopharm for the supply of human recombinant insulin in South East Asia, including Malaysia. Source: Global Newswire 19/3/2019